Biologics Are Superior to Immunomodulators in Prevention of Post-Operative Recurrence of Crohn's Disease

Selamawit Tarekegn; Kristin Oimoen; Yelena Zadvornova; Daniel Eastwood; Mazen Issa; Amar S. Naik; Dan Joseph Stein; Nanda Venu; Lilani P. Perera

doi:10.1016/s0016-5085(11)62450-5

Related publications

Article2018

Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection

Anthony W.H. Chan, Jian‐Hong Zhong, Sarah Berhane, Hidenori Toyoda, Alessandro Cucchetti, Keqing Shi, Toshifumi Tada, Charing C. N. Chong, Bang‐De Xiang, Le‐Qun Li, Paul B.S. Lai, Vincenzo Mazzaferro, Marta García‐Fiñana, Masatoshi Kudo, Takashi Kumada, Sasan Roayaie, Philip J. Johnson

Editorial Material2020

The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celebration of research collaboration in British dermatology

Zenas Z N Yiu, K.J. Mason, Catherine Smith, Christopher Em Griffiths

Article2024

Real-world evidence of combined treatment of biologics and exclusive enteral nutrition in patients with ileum-dominant Crohn's disease: A multicenter study

Wei Wang, Anning Yin, Jing Wang, Jiao Li, Jingyun Cheng, Jian Jian Kang, Yaqing Xu, Yueyue Lu, Yuanping Yang, Juan Su, Qian Zhou, Ya Liu, Zhishun Tang, Haixia Ren, Weiwei Li, Weiguo Dong, Baoping Yu, Ping An

Article2025

Drug survival of IL‐23 and IL‐17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study

Leila Motedayen Aval, Zenas Z N Yiu, Oras Alabas, Christopher Em Griffiths, Nick J. Reynolds, Philip Hampton, Catherine Smith, Richard B. Warren

Article2025

Drug Repurposing to Inhibit Oncostatin M in Crohn’s Disease

Faranak Bahramimehr, Axel Guthart, Yuanping Hai, Mona Dawood, Rümeysa Yücer, Nasim Shahhamzehei, Ralf Weiskirchen, Wilfried Roth, Wolfgang Stremmel, Gerhard Bringmann, Thomas Efferth